Alnylam Pharmaceuticals, Inc.
Lobbying group · Jul 2025 – Sep 2026
Alnylam Pharmaceuticals, Inc. spent $1.7M lobbying the federal government (Jul 2025 – Sep 2026), mostly on medicare & medicaid, media, trade. It used 14 lobbyists, including people who worked for 5 members of Congress.
- Spent on lobbying
- $1.7M
- Lobbyists
- 14
- Bills lobbied
- 4
- Issues
- 4
Spending by quarter
- 2025 Q3$390K
- 2025 Q4$390K
- 2026 Q1$430K
- 2026 Q2$450K
Issues lobbied
- Medicare & Medicaid
- Media
- Trade
- Pharmacy
Bills lobbied on
- H.R. 1672: Maintaining Investments in New Innovation Act18 reports
- H.R. 94614 reports
- S. 186210 reports
- H.R. 49934 reports
Lobbying firms hired
- Alnylam Pharmaceuticals, Inc.$1.7M
- Tiber Creek Group$240K
- Lmh Strategic Solutions$240K
- Splitoak Strategies LLC$240K
- Todd Strategy Group$240K
- Capitol Counsel LLC$150K
Lobbyists who worked in Congress
- Curtis Rhyne
Rep. Virginia Foxx (2008-2009), House Republican Study Committee (2009-2014), Rep. Richard Hudson (2014-2017), Rep…Richard Hudson (R-NC) - Curtis Rhyne
Rep. Virginia Foxx (2008-2009), House Republican Study Committee (2009-2014), Rep. Richard Hudson (2014-2017), Rep…Virginia Foxx (R-NC) - Jeff Lucas
Health Policy Advisor, Senator Bill Cassidy; Legislative Assistant/Sr. Legislative Assistant/Legislative…Bill Cassidy (R-LA) - Katherine Cotton
Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett GuthrieBrett Guthrie (R-KY) - Eric Bergren
Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior…Brett Guthrie (R-KY) - Margaret Herman
Legislative Aide, Senator Mark Warner (June 2017-May 2019); Legislative Assistant, Rep. Mikie Sherrill (May 2019-Jan…Mark R. Warner (D-VA)
Agencies contacted
- House Of Representatives · 30
- Senate · 30
- Food & Drug Administration (Fda) · 4
- Executive Office of the President (Eop) · 4
- Health & Human Services, Dept of (Hhs) · 4
Related
Filings
- 2026 Q2 report$50K
- 2026 Q2 report$60K
- 2026 Q2 report$30K
- 2026 Q2 report$60K
- 2026 Q2 report$60K
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “Alnylam Pharmaceuticals, Inc.: Lobbying Spending, Issues & Bills,” https://www.capitolreceipts.com/lobbying/calnylampharmaceuticals/alnylam-pharmaceuticals-inc (accessed 2026-10-15).